Clincosm LogoSign in Get a demo

Neoplasms

Showing NaN - NaN of 85
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in United States (GSK4524101, Niraparib)

Not yet recruiting
  • Neoplasms
  • San Francisco, California
  • +5 more
Oct 5, 2023

Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Sep 15, 2023

Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Jul 5, 2023

Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

Active, not recruiting
  • Neoplasms
  • +3 more
  • Sarasota, Florida
  • +17 more
Jan 27, 2023

Tumors Trial in Worldwide (Encorafenib, Cetuximab, Oxaliplatin)

Recruiting
  • Neoplasms
  • Phoenix, Arizona
  • +396 more
Jan 25, 2023

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Tumors Trial in Worldwide (CC-95251, Rituximab, Cetuximab)

Recruiting
  • Neoplasms
  • Birmingham, Alabama
  • +62 more
Jan 19, 2023

Hematologic Tumor, Tumors Trial in Gainesville, Baltimore, Houston (CC-486)

Active, not recruiting
  • Hematologic Neoplasm
  • Neoplasms
  • Gainesville, Florida
  • +2 more
Jan 12, 2023

Tumors Trial in Canada, United Kingdom, United States (BI 754091)

Active, not recruiting
  • Neoplasms
  • BI 754091
  • Sarasota, Florida
  • +12 more
Jan 9, 2023

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)

Recruiting
  • Non-Small Cell Lung Cancer
  • +13 more
  • furmonertinib 240 mg
  • +2 more
  • Yuma, Arizona
  • +37 more
Dec 14, 2022

Tumors Trial in Spain, United States (TSR-022, Nivolumab, TSR-042)

Recruiting
  • Neoplasms
  • Goodyear, Arizona
  • +71 more
Dec 9, 2022

Tumors, Lymphoma, Hematologic Tumors Trial in Ukraine, United States (TAK-981)

Recruiting
  • Neoplasms
  • +2 more
  • La Jolla, California
  • +15 more
Dec 7, 2022

Tumors Trial in United States (letetresgene autoleucel (GSK3377794), Cyclophosphamide, Fludarabine)

Completed
Has Results
  • Neoplasms
  • letetresgene autoleucel (GSK3377794)
  • +2 more
  • Tampa, Florida
  • +5 more
Oct 31, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Tumors Trial in Worldwide (CC-90011, Nivolumab)

Active, not recruiting
  • Neoplasms
  • Augusta, Georgia
  • +77 more
Nov 8, 2022

Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)

Active, not recruiting
Has Results
  • Neoplasms
  • +6 more
  • Scottsdale, Arizona
  • +7 more
Oct 31, 2022

Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

Recruiting
  • Lung Neoplasms
  • +23 more
  • La Jolla, California
  • +35 more
Oct 6, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Tumors Trial in United States (Niraparib Tablet, Niraparib Capsule)

Active, not recruiting
  • Neoplasms
  • Niraparib Tablet
  • Niraparib Capsule
  • Encinitas, California
  • +15 more
Sep 7, 2022

Tumors Trial in Worldwide (GSK6097608, Dostarlimab, GSK4428859A (EOS884448))

Recruiting
  • Neoplasms
  • Los Angeles, California
  • +9 more
Aug 26, 2022

Tumors Trial in Worldwide (Gene-modified (GM) T cell therapy)

Recruiting
  • Neoplasms
  • Gene-modified (GM) T cell therapy
  • Birmingham, Alabama
  • +173 more
Aug 1, 2022

Tumors, Tenosynovial Giant Cell Tumor Trial in Denver, Atlanta, Houston (ABSK021)

Recruiting
  • Neoplasms
  • Tenosynovial Giant Cell Tumor
  • Denver, Colorado
  • +2 more
Jul 25, 2022

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Tumors Trial in Worldwide (GSK3368715)

Terminated
Has Results
  • Neoplasms
  • Los Angeles, California
  • +8 more
Mar 1, 2022

Tumors, Tumor Metastasis, Metastatic Gastrointestinal Carcinoid Tumor Trial in China, United States (EMB-01)

Recruiting
  • Neoplasms
  • +2 more
  • Canton, Ohio
  • +3 more
Apr 12, 2022